The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology

Overview

Pre-Order Now!
Master Hematology CME

Gain essential knowledge with The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology online CME program. This expert-led course covers key topics such as molecular genetics, leukemia, lymphomas, and bone marrow disorders, helping you refine patient care strategies and excel on your board exam. Continuing medical education areas for practice improvement include:

• Hematopoiesis and Cytokines
• Immune and Non-immune Hemolytic Anemia
• Molecular Genetics of Cancer
• Thalassemia and Other Hemoglobinopathies
• Acquired Thrombocytopenias
• Von Willebrand Disease and Congenital Platelet Disorders
• Transfusion Medicine
• and many more…

This program is also available as part of the combined Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology CME course found here.

Topics / Speakers

Molecular Genetics of Cancer - Marios Giannakis, MD, PhD

Infections in Cancer Patients - Lindsey Baden, MD

Opioid Prescribing for Cancer-Related Pain - Kate M. Lally, MD

Communication – The Key to Excellence in End-of-Life Care - Eilann C. Santo, MD, MPH

Biology of Hematopoietic Stem Cell Transplantation - Robert J. Soiffer, MD

Biology of Acute Leukemia and Myelodysplastic Syndromes - Zuzana Tothova, MD, PhD

The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now - Daniel J. DeAngelo, MD, PhD

Myelodysplastic Syndrome - Eric S. Winer, MD

Chronic Myelogenous Leukemia - Marlise R. Luskin, MD

Myeloproliferative Syndromes - Joan-Chi How, MD

Multiple Myeloma - Kenneth C. Anderson, MD

Waldenstrom Macroglobulemia and Amyloidosis - Jorge J. Castillo, MD

Low Grade Lymphomas - Caron A. Jacobson, MD

Non-Hodgkin's Lymphoma - Diffuse Large B-Cell and Burkitt - Eric D. Jacobsen, MD

Non-Hodgkin Lymphoma - Mantle Cell and T-Cell - Eric D. Jacobsen, MD

Hodgkin's Lymphoma - Reid W. Merryman, MD

Diagnosis and Treatment of CLL and Related B-Cell Malignancies - Matthew S. Davids, MD

Hematopoiesis and Cytokines - David B. Sykes, MD, PhD

Acquired Bone Marrow Failure - Julie-Aurore Losman, MD, PhD

Congenital Bone Marrow Failure - Grant Rowe, MD, PhD

HLH - Sarah Nikiforow, MD

Anemia – An Overview - Robert Stern, MD

Iron Deficiency and Iron Overload - Mark D. Fleming, MD, Dphil

Immune Hemolytic Anemia - Arielle L. Langer, MD, MPH

Non-immune Hemolytic Anemia - David E. Golan, PhD, MD

Sickle Cell Disease - Maureen M. Achebe, MD, MPH

Thalassemia and Other Hemoglobinopathies - Matthew M. Heeney, MD

Disorders of Neutrophils - Nancy Berliner, MD

Acquired Thrombocytopenias - Elisabeth M. Battinelli, MD, PhD

Hemophilia - Stacy E. Croteau, MD

Von Willebrand Disease and Congenital Platelet Disorders - Nathan T. Connell, MD, MPH

Congenital and Acquired Thrombophilia - Kenneth A. Bauer, MD

Managing Challenging Cases of Venous Thrombosis in Patients with Cancer - Jean M. Connors, MD

Transfusion Medicine for the Clinician - Marie A. Hollenhorst, MD, PhD

Faculty

Accreditation / Pass Guarantee

Accreditation

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing designates this enduring material for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Date of Original Release: TBD
Termination Date: TBD

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

At the conclusion of this activity, the participant will be able to:

• Apply current/recommended hematology guidelines in clinical practice
• Perform differential diagnosis of complex clinical presentations related to hematologic disorders
• Identify/apply current therapeutic options for specific hematologic disorders
• Review and interpret up-to-date literature relevant to clinical practice in hematology
• Demonstrate knowledge of pathophysiology as it applies to management of hematology disorders
• Apply knowledge gained to the ABIM certification/recertification hematology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing hematology specialists (MDs), and other professional affiliates (internists with an interest in hematology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the areas of hematology medicine.

Board Pass Guarantee

We Guarantee You'll Pass! Diligent course study and successful completion of the CME quiz provides the strongest likelihood of passing board certification or maintenance of certification exams. Oakstone is so confident of your success that we guarantee it. If you do not pass your exam on the first attempt, mail us a copy of your board failure notification, plus our system certificate reflecting your successful completion of the CME quizzes for the board review product purchased. You will receive a credit for the purchase price paid (less any discounts or premium), which you may apply to future purchases with Oakstone. Your exam record will be destroyed. Your board failure notification can be mailed to: Oakstone, P.O. Box 190165, Birmingham, AL 35219. If you have any questions on this policy, please feel free to contact Customer Service at 1-800-633-4743.

Quick Facts

Provider: Brigham and Women's Hospital and
Dana-Farber Cancer Institute

Course Directors:

Maureen M. Achebe, MD, MPH

Associate Professor of Medicine

Harvard Medical School

Clinical Director

Division of Hematology

Department of Medicine

Brigham and Women's Hospital

Nancy Berliner, MD

Professor of Medicine

Harvard Medical School

Chief, Division of Hematology

Department of Medicine

Brigham and Women's Hospital

Credits: Earn AMA PRA Category 1 Credits™ and ABIM MOC points